Search results
Aiolos Bio raises $245M on prospect of better asthma drug
BioPharma Dive via Yahoo Finance· 8 months agoA new biotechnology company has raised $245 million in a Series A financing round on the promise of...
GSK to buy asthma drug startup Aiolos for $1B
BioPharma Dive via Yahoo Finance· 5 months agoOver the span of five months, biotechnology startup Aiolos Bio launched, raised initial funding from venture investors and negotiated a $1 billion buyout...
Jenfi raises more funding for its 'growth capital as a service' platform
TechCrunch· 1 year agoJenfi, a “growth-capital-as-a-service” platform, can provide online businesses with revenue-based...
Diagonal starts up with $128M to make better ‘activator’ antibody drugs
BioPharma Dive via Yahoo Finance· 3 months agoThe startup claims to have a more efficient way to develop biologic drugs that treat disease by...
Fidelity makes first acquisition in 7 years, snapping up fintech Shoobx
TechCrunch· 1 year agoInvestment giant Fidelity announced today that it has acquired Shoobx, a venture-backed fintech...
Investors put $400M into biotech licensing obesity drugs from China
BioPharma Dive via Yahoo Finance· 1 month agoThe biotech, tentatively named Hercules CM Newco, has rights to three incretin drugs discovered by...
IFM, an unorthodox biotech startup, scores third buyout with Novartis deal
BioPharma Dive via Yahoo Finance· 3 months agoWith a decision by the Swiss pharma to acquire another one of its subsidiaries, IFM Therapeutics has...
Peter Thiel backs electronics marketplace PriceOye in maiden Pakistan investment
TechCrunch· 2 years agoA Pakistani startup, which has taken inspiration from China's JD.com and India's Flipkart to build a...
Be Bio’s haemophilia B treatment gains FDA orphan drug status
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoThe US Food and Drug Administration (FDA) has granted orphan drug designation to Be Biopharma’s (Be...
Gemini Therapeutics Announces Reverse Merger Pact With Hematology-Focused Company
Benzinga via Yahoo Finance· 2 years agoGemini Therapeutics Inc (NASDAQ: GMTX) and privately held Disc Medicine Inc have entered into a...
